Abstract
The ongoing COVID-19 pandemic has affected millions of lives adversely in the last 2 years, and the future course of the pandemic remains unknown. Initially, COVID-19 infection was thought to be an acute respiratory illness, but slowly it became clear that it is a multi-system disease involving almost all body organs. Still more alarming is the realization that this infection is not as “acute” only as previously believed but has lasting effects in various organ systems. Kidneys are no exception, not only being involved during acute COVID-19 infection in multiple ways but also are important organs, in which infection leads to chronic kidney disease with varying manifestations. This review will restrict the majority of the discussion to long-term sequelae of COVID-19 concerning kidneys.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heung M, Chawla LS. Acute kidney injury: gateway to chronic kidney disease. Nephron Clin Pract. 2014 Sep 24;127(1–4):30–4.
Chapter 1: Definition and classification of CKD. Kidney Int Suppl. 2013 Jan;3(1):19–62.
Silver SA, Beaubien-Souligny W, Shah PS, et al. The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis. Kidney Med. 2021 Feb;3(1):83–98.e1.
Mohamed MMB, Velez JCQ. Proteinuria in COVID-19. Clin Kidney J. 2021 Mar 1;14(Supplement_1):i40–7.
Long JD, Strohbehn I, Sawtell R, et al. COVID-19 survival and its impact on chronic kidney disease. Transl Res J Lab Clin Med. 2021 Nov 10;S1931-5244(21):00266–8.
Callender LA, Curran M, Bates SM, et al. The impact of pre-existing co-morbidities and therapeutic interventions on COVID-19. Front Immunol. 2020;11:1991.
Sharma P, Ng JH, Bijol V, et al. Pathology of COVID-19-associated acute kidney injury. Clin Kidney J. 2021 Mar 1;14(Supplement_1):i30–9.
Shimmel A, Shaikhouni S, Mariani L. Current understanding of clinical manifestations of COVID-19 in glomerular disease. Glomerular Dis. 2021;1(4):250–64.
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601–15.
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021 Aug 9;11(1):16144.
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220–32.
Bouquegneau A, Huart J, Lutteri L, et al. POS-196 patients with covid-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Kidney Int Rep. 2021 Apr 1;6(4):S82.
Writing Committee for the COMEBAC Study Group, Morin L, Savale L, Pham T, et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021 Apr 20;325(15):1525–34.
Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021 Mar 30;11(3):e048391.
Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol JASN. 2020 Jun;31(6):1157–65.
Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in Long COVID. J Am Soc Nephrol JASN. 2021 Nov;32(11):2851–62.
Nugent J, Aklilu A, Yamamoto Y, et al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Netw Open. 2021 Mar 1;4(3):e211095.
Kataria A, Yakubu I, Winstead R, et al. COVID-19 in kidney transplantation: epidemiology, management considerations, and the impact on kidney transplant practice. Transplant Direct. 2020 Aug;6(8):e582.
Meshram HS, Kute VB, Patel H, et al. Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: a retrospective cohort from a developing nation. Transpl Infect Dis. 2021 Aug;23(4):e13629.
Basic-Jukic N, Juric I, Furic-Cunko V, et al. Follow-up of renal transplant recipients after acute COVID-19—a prospective cohort single-center study. Immun Inflamm Dis. 2021;9(4):1563–72.
Lutchmansingh DD, Knauert MP, Antin-Ozerkis DE, et al. A clinic blueprint for post-coronavirus disease 2019 recovery: learning from the past. Looking to the Future Chest. 2021 Mar;159(3):949–58.
Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021 Mar;31(372):n693.
Chen G, Li X, Gong Z, et al. Hypertension as a sequela in patients of SARS-CoV-2 infection. PLoS One. 2021 Apr 28;16(4):e0250815.
Husain-Syed F, Villa G, Wilhelm J, et al. Renal markers for monitoring acute kidney injury transition to chronic kidney disease after COVID-19. Nephrol Dial Transplant. 2021 Nov 1;36(11):2143–7.
Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol. 2021 Dec;17(12):792–3.
Haendel MA, Chute CG, Bennett TD, et al. The national COVID cohort collaborative (N3C): rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021 Mar 1;28(3):427–43.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Arunkumar, S., Agarwal, S.K. (2022). Renal Abnormalities Following COVID-19. In: Mohan, A., Mittal, S. (eds) Post COVID-19 Complications and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-4407-9_9
Download citation
DOI: https://doi.org/10.1007/978-981-19-4407-9_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-4406-2
Online ISBN: 978-981-19-4407-9
eBook Packages: MedicineMedicine (R0)